033 Drug eluting stent percutaneous angioplasty The experience of the tertiary region of Sfax by Abid, Leila et al.
© Elsevier Masson SAS. All rights reserved.
 
Archives of Cardiovascular Diseases Supplements (2011) 3, 1-25 11
erence diameter was 3.9 ± 0.5mm. LM lesion was non distal in 34 %, and
distal in 66 % of pts. In this group, 72 % were located at the bifurcation
including LAD, LCX or both ostia affected. All patients were successfully
treated on the LM (stent length 15.7 ± 5.2 mm) and a final kissing balloon
inflation was performed in 90%. Apart from the LM stenosis, a total of 1.2 ±
0.8 lesions were treated during the hospitalisation (total stent length 47 ±
16mm). In-hospital MACCE rate was 4.5 % with 2.6% of mortality ; at 9-
month follow-up (FU), the global rate of event-free survival was 93.5 % with
a very low angiographic restenosis rate of 3 %. Between 9 and 36-month clin-
ical FU, there were one sudden death, 6 extra-cardiac deaths (total mortality
7%), one recurrent angina and 1 cardiac failure. Event free survival was 84 %.
Conclusion: LM PCI using the TAXUS stent is feasible and safe at long-
term follow-up. Stenting deserves to be considered a safe and effective alter-
native to CABG in institutions performing large numbers of PCIs. 
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Introduction: Several clinical trials have validated the effectiveness of
drug eluting stents (DES) and its benefit comparing to bare-metal stent for res-
tenosis rate reduction after angioplasty. But the major disadvantage of DES is
thrombosis. The aim of this study is to describe clinical and angiographic out-
comes of DES implantation in Sfax Cardiology Departments (public and pri-
vate centers). 
Patients and methods: Our study is retrospective including 619 patients
undergoing percutaneous angioplasty by 769 eluding stents during the period
between juillet 2003 and June 2009.
Results: The mean age was 63,25 years and most patients were men
(80,7%). The majority of patients (61, 6%) were diabetic. Most patients (46,
3%) had multivessel disease. Coronary lesion sites were located mainly on the
left descending coronary artery at 71, 4%. The mean diameter stent was 2, 93
± 0,37 mm, and the mean length was 26,95± 6,91mm. Coronary lesion was in
the most time long (in 43,1%). We used Taxus stents in 81,4% of cases. The
stenting was direct in 72,1% of procedures, and after dilatation in 22 proce-
dures%. A post inflation was achieved in 11,3% of procedures. The mean of
pression inflation was 14, 29 mmhg. The angiographic success was noted in
100%. The mean follow-up was 18, 26 months. Acute instent thrombosis
occurred in 3,7% (23 patients/619 patients). One case of acute thrombosis, 21
cases of subacute thrombosis, one case of late thrombosis, no case of very-
late  thrombosis was noted. On the Follow up , an angiographic control was
performed in 8,3% des cas (49 patients). A restenosis in stent was noted in
16% and new lesions were noted in 3,6% of cases. MACE rate was 10,2%
with 2,5% of mortality.
Conclusion: The high price of drug eluting stents relative to bare stents
has been an obstacle to widespread utilization of drug eluting stents in our ter-
tiary region. These latter are more interesting for diabetic persons and complex
lesions but they are limited by the risk of acute and late thrombosis. 
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Introduction: Normal renal function has been Shown in epidemiological
studies and clinical trials to be an independent predictor of survival.
Objective: To determine whether creatinine clearance at the time of hos-
pital admission is an independent predictor of hospital mortality and adverse
outcomes in patients with ST -segment elevation myocardial infarction(
STEMI).
Patients: 231 patients hospitalized with STEMI in our institution between
January 2005 to December 2006.
In-hospital outcomes were compared for patients with creatinine clearance
rates of > 60 ml/min (normal renal function) and ≤60 ml/min (moderate and
severe Baseline Renal Dysfunction, BRD).
Results: Patients with BRD were older, were more likely to be women, and
presented to with more comorbidites. 
Patients with BRD had presented more ischemic atrial fibrillation (p=0.033).
A greater number of patients with BRD had impaired left ventricle systolic
performance, so this patients had more presented acute heart failure (p=0.008),
and cardiogenic shock (p=0.017).
Patients with worsened renal function had presented more mechanical compli-
cations: 
-free wall rupture and apical ventricular septal defect , in two separate cases
,following anterior myocardial infarction , leading to immediate death of these
two patients.
-ischemic mitral regurgitation in one case
The in hospital death rate of BRD patients was 6.6%, compared with 0.9% for
non BRD patients.
In comparison with patients with normal or minimally impaired renal function,
patients with moderate renal dysfunction were seven times more likely to die
(odds ratio 7, 09, 95% confidence interval 0.7 to 68) after adjustment for other
potentially confounding Variables.
The risk of bleeding episodes was increased in patients with worsened renal
functionOnly one patient, with moderate renal dysfunction, had an ischemic
stroke.
Conclusion: In patients with ACS, creatinine clearance is an important
independent predictor of hospital death. 
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Ischemic heart disease is the most common cause of death in patients with
chronic kidney disease (CKD). Patients with CKD who develop an ST eleva-
tion myocardial infarction(STEMI) have a poor prognosis, with >70% mor-
tality at 2 years. Despite this heavy burden of disease, the optimal
management of ACS in this patient population is unknown. Our goal was to
compare the effect of coronary revascularization or medical therapy alone on
the long-term survival of patients with CKD presenting with STEMI. From
2005 to 2007, data were prospectively collected on 231 patients admitted to a
coronary care unit with the diagnosis of STEMI. Of these, 112 had preserved
renal function, and 119 had significant renal dysfunction, as defined by the
National Kidney Foundation in the Kidney Disease Outcomes Quality Initia-
tive classification of kidney function as an estimated glomerular filtration rate
of <60 ml/min/1.73 m(2).
Long-term survival was assessed and outcomes were compared according
to whether patients were treated with medical therapy alone or if they under-
went a percutaneous or surgical revascularization procedure. Follow-up infor-
mation was available in 68 patients up to 1 year after the index hospitalization.
Of the 119 patients with significant renal dysfunction, ten underwent coronary
artery bypass surgery, 77underwent percutaneous coronary revascularization,
eight underwent a diagnostic cardiac catheterization and were subsequently
treated medically. Percutaneous coronary revascularization was associated
with superior long-term survival. Surgical revascularization was an indepen-
dent predictor of MACCE at one tear after index hospitalization ((p=0.03,
HR= 2.760; 95% CI 1.101-6.920).
In conclusion, patients with severe CKD and STEMI had improved long-
term survival when treated with percutaneous coronary revascularization.
